These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21889147)
1. Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. Turpeinen H; Raitoharju E; Oksanen A; Oksala N; Levula M; Lyytikäinen LP; Järvinen O; Creemers JW; Kähönen M; Laaksonen R; Pelto-Huikko M; Lehtimäki T; Pesu M Atherosclerosis; 2011 Dec; 219(2):799-806. PubMed ID: 21889147 [TBL] [Abstract][Full Text] [Related]
2. A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure. Turpeinen H; Seppälä I; Lyytikäinen LP; Raitoharju E; Hutri-Kähönen N; Levula M; Oksala N; Waldenberger M; Klopp N; Illig T; Mononen N; Laaksonen R; Raitakari O; Kähönen M; Lehtimäki T; Pesu M Hum Genet; 2015 Jun; 134(6):627-36. PubMed ID: 25813623 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease. Suur BE; Chemaly M; Lindquist Liljeqvist M; Djordjevic D; Stenemo M; Bergman O; Karlöf E; Lengquist M; Odeberg J; Hurt-Camejo E; Eriksson P; Ketelhuth DFJ; Roy J; Hedin U; Nyberg M; Matic L Front Pharmacol; 2022; 13():988561. PubMed ID: 36188622 [TBL] [Abstract][Full Text] [Related]
4. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426 [TBL] [Abstract][Full Text] [Related]
5. Kindlin 3 (FERMT3) is associated with unstable atherosclerotic plaques, anti-inflammatory type II macrophages and upregulation of beta-2 integrins in all major arterial beds. Oksala N; Pärssinen J; Seppälä I; Klopp N; Illig T; Laaksonen R; Levula M; Raitoharju E; Kholova I; Sioris T; Kähönen M; Lehtimäki T; Hytönen VP Atherosclerosis; 2015 Sep; 242(1):145-54. PubMed ID: 26188538 [TBL] [Abstract][Full Text] [Related]
6. Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Perisic L; Hedin E; Razuvaev A; Lengquist M; Osterholm C; Folkersen L; Gillgren P; Paulsson-Berne G; Ponten F; Odeberg J; Hedin U Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2432-43. PubMed ID: 23908247 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of PCSK6 by lipid oxidation products: A possible role in atherosclerosis. Testa G; Staurenghi E; Giannelli S; Sottero B; Gargiulo S; Poli G; Gamba P; Leonarduzzi G Biochimie; 2021 Feb; 181():191-203. PubMed ID: 33359561 [TBL] [Abstract][Full Text] [Related]
12. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis. Stawowy P; Kallisch H; Borges Pereira Stawowy N; Stibenz D; Veinot JP; Gräfe M; Seidah NG; Chrétien M; Fleck E; Graf K Virchows Arch; 2005 Apr; 446(4):351-9. PubMed ID: 15756593 [TBL] [Abstract][Full Text] [Related]
14. PCSK9 Biology and Its Role in Atherothrombosis. Barale C; Melchionda E; Morotti A; Russo I Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070931 [TBL] [Abstract][Full Text] [Related]
15. Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia. Kataoka Y; Harada-Shiba M; Nakao K; Nakashima T; Kawakami S; Fujino M; Kanaya T; Nagai T; Tahara Y; Asaumi Y; Hori M; Ogura M; Goto Y; Noguchi T; Yasuda S J Clin Lipidol; 2017; 11(2):413-421.e3. PubMed ID: 28502498 [TBL] [Abstract][Full Text] [Related]
17. Significance of BAFF/APRIL Expression and Their Receptors in Pediatric Patients With Acute Lymphoblastic Leukemia. Sun B; Li L; Xu M; Wang X; Wang F; Ni H J Pediatr Hematol Oncol; 2016 Apr; 38(3):167-72. PubMed ID: 26950089 [TBL] [Abstract][Full Text] [Related]
18. Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. Bernelot Moens SJ; van Leuven SI; Zheng KH; Havik SR; Versloot MV; van Duivenvoorde LM; Hahne M; Stroes ES; Baeten DL; Hamers AA PLoS One; 2016; 11(11):e0164690. PubMed ID: 27820817 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of ANGPTL4 messenger RNA and protein in severely calcified carotid plaques. Katano H; Yamada K J Stroke Cerebrovasc Dis; 2014; 23(5):933-47. PubMed ID: 24075588 [TBL] [Abstract][Full Text] [Related]
20. The molecular biology of furin-like proprotein convertases in vascular remodelling. Stawowy P; Kappert K Methods Mol Biol; 2011; 768():191-206. PubMed ID: 21805243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]